Intrahepatic Levels of CXCR3-Associated Chemokines Correlate With Liver Inflammation and Fibrosis in Chronic Hepatitis C

被引:188
作者
Zeremski, Marija [1 ,2 ]
Petrovic, Lydia M. [3 ]
Chiriboga, Luis [3 ]
Brown, Queenie B. [1 ,2 ]
Yee, Herman T. [3 ]
Kinkhabwala, Milan [4 ,5 ]
Jacobson, Ira M. [1 ,2 ]
Dimova, Rositsa [6 ]
Markatou, Marianthi [6 ]
Talal, Andrew H. [1 ,2 ]
机构
[1] Weill Cornell Med Coll, Dept Med, Div Gastroenterol & Hepatol, New York, NY 10065 USA
[2] Weill Cornell Med Coll, Ctr Study Hepatitis C, New York, NY 10065 USA
[3] NYU, Sch Med, Dept Pathol, New York, NY USA
[4] Montefiore Med Ctr, Bronx, NY 10467 USA
[5] Albert Einstein Coll Med, Bronx, NY 10467 USA
[6] Columbia Univ, Dept Biostat, Mailman Sch Publ Hlth, New York, NY USA
基金
美国国家卫生研究院;
关键词
D O I
10.1002/hep.22500
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Chemokines, chemotactic cytokines, may promote hepatic inflammation in chronic hepatitis C virus (HCV) infection through the recruitment of lymphocytes to the liver parenchyma. We evaluated the association between inflammation and fibrosis and CXCR3-associated chemokines, interferon-gamma (IFN-gamma)-inducible protein 10 (IP-10/CXCL10), monokine induced by IFN-gamma (Mig/CXCL9), and interferon-inducible T cell a chemoattractant (I-TAC/CXCL11 I), in HCV infection. Intrahepatic mRNA expression of these chemokines was analyzed in 106 chronic HCV-infected patients by real-time PCR. The intrahepatic localization of chemokine producer cells and CXCR3(+) lymphocytes was determined in selected patients by immunohistochemistry. We found elevated intrahepatic mRNA expression of all three chemokines, most markedly CXCL10, in chronic HCV-infected patients with higher necroinflammation and fibrosis. By multivariable multivariate analysis, intrahepatic CXCL10 mRNA expression levels were significantly associated with lobular necroinflammatory grade and HCV genotype 1. In the lobular region, CXCL10-expressing and CXCL9-expressing hepatocytes predominated in areas with necroinflammation. Strong CXCL11 expression was observed in almost all portal tracts, whereas CXCL9 expression varied considerably among portal tracts in the same individual. Most intrahepatic lymphocytes express the CXCR3 receptor, and the number of CXCR3(+) lymphocytes was increased in patients with advanced necroinflammation. Conclusion: These findings suggest that the CXCR3-associated chemokines, particularly CXCL10, may play an important role in the development of necroinflammation and fibrosis in the liver parenchyma in chronic HCV infection. (HEPATOLOGY 2008;48:1440-1450.)
引用
收藏
页码:1440 / 1450
页数:11
相关论文
共 25 条
[1]  
AFDHAL NH, 2004, SEMIN LIVER DIS S2, V2, P3
[2]  
[Anonymous], REV GASTROENTEROL DI
[3]  
Apolinario A, 2002, AM J GASTROENTEROL, V97, P2861, DOI 10.1111/j.1572-0241.2002.07054.x
[4]  
*APPL BIOS, 1997, US B APPL BIOS, V2, P11
[5]  
Bertolino Patrick, 2000, Hepatology, V31, P1374, DOI 10.1053/jhep.2000.8376
[6]   Molecular profiling of early stage liver fibrosis in patients with chronic hepatitis C virus infection [J].
Bièche, I ;
Asselah, T ;
Laurendeau, I ;
Vidaud, D ;
Degot, C ;
Paradis, V ;
Bedossa, P ;
Valla, DC ;
Marcellin, P ;
Vidaud, M .
VIROLOGY, 2005, 332 (01) :130-144
[7]   DNA microarray analysis of chimpanzee liver during acute resolving hepatitis C virus infection [J].
Bigger, CB ;
Brasky, KM ;
Lanford, RE .
JOURNAL OF VIROLOGY, 2001, 75 (15) :7059-7066
[8]   Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s [J].
Bonecchi, R ;
Bianchi, G ;
Bordignon, PP ;
D'Ambrosio, D ;
Lang, R ;
Borsatti, A ;
Sozzani, S ;
Allavena, P ;
Gray, PA ;
Mantovani, A ;
Sinigaglia, F .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (01) :129-134
[9]   Pathogenesis of chronic hepatitis C: Immunological features of hepatic injury and viral persistence [J].
Cerny, A ;
Chisari, FV .
HEPATOLOGY, 1999, 30 (03) :595-601
[10]   Association of pretreatment serum interferon γ inducible protein 10 levels with sustained virological response to peginterferon plus ribavirin therapy in genotype 1 infected patients with chronic hepatitis C [J].
Diago, M ;
Castellano, G ;
García-Samaniego, J ;
Pérez, C ;
Fernández, I ;
Romero, M ;
Iacono, OL ;
García-Monzón, C .
GUT, 2006, 55 (03) :374-379